
Mendelics is a leading Brazilian laboratory specializing in genetic diagnostic tests, founded in 2012. They are pioneers and leaders in Next Generation Sequencing (NGS) in Latin America, offering a wide range of genetic tests for various medical specialties including oncology, rare diseases, and reproductive medicine. Their proprietary platform, Abracadabra®, utilizes artificial intelligence for precise and efficient genetic analysis, earning them an MIT innovation award. Mendelics holds prestigious international accreditations such as CAP, PALC, and ISO, ensuring high-quality standards. They aim to make genetic diagnostics fast, accurate, and accessible, with over 100,000 genetic tests performed and a large database of Brazilian and Latin American variants.

Mendelics is a leading Brazilian laboratory specializing in genetic diagnostic tests, founded in 2012. They are pioneers and leaders in Next Generation Sequencing (NGS) in Latin America, offering a wide range of genetic tests for various medical specialties including oncology, rare diseases, and reproductive medicine. Their proprietary platform, Abracadabra®, utilizes artificial intelligence for precise and efficient genetic analysis, earning them an MIT innovation award. Mendelics holds prestigious international accreditations such as CAP, PALC, and ISO, ensuring high-quality standards. They aim to make genetic diagnostics fast, accurate, and accessible, with over 100,000 genetic tests performed and a large database of Brazilian and Latin American variants.